Cargando…
AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855822/ https://www.ncbi.nlm.nih.gov/pubmed/29463000 http://dx.doi.org/10.3390/ijms19020600 |
_version_ | 1783307187707183104 |
---|---|
author | Wang, Qiuyu Jin, Lili Wang, Huan Tai, Sijia Liu, Hongsheng Zhang, Dianbao |
author_facet | Wang, Qiuyu Jin, Lili Wang, Huan Tai, Sijia Liu, Hongsheng Zhang, Dianbao |
author_sort | Wang, Qiuyu |
collection | PubMed |
description | Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the anti-LPS activity of the synthetic peptide AWRK6, which is derived from antimicrobial peptide dybowskin-2CDYa, has been investigated in vitro and in vivo. The positively charged α-helical AWRK6 was found to be effective in blocking the binding of LBP (LPS binding protein) with LPS in vitro using ELISA. In a murine endotoxemia model, AWRK6 offered satisfactory protection efficiency against endotoxemia death, and the serum levels of LPS, IL-1β, IL-6, and TNF-α were found to be attenuated using ELISA. Further, histopathological analysis suggested that AWRK6 could improve the healing of liver and lung injury in endotoxemia mice. The results of real-time PCR and Western blotting showed that AWRK6 significantly reversed LPS-induced TLR4 overexpression and IκB depression, as well as the enhanced IκB phosphorylation. Additionally, AWRK6 did not produce any significant toxicity in vivo and in vitro. In summary, AWRK6 showed efficacious protection from LPS challenges in vivo and in vitro, by blocking LPS binding to LBP, without obvious toxicity, providing a promising strategy against LPS-induced inflammatory responses. |
format | Online Article Text |
id | pubmed-5855822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58558222018-03-20 AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response Wang, Qiuyu Jin, Lili Wang, Huan Tai, Sijia Liu, Hongsheng Zhang, Dianbao Int J Mol Sci Article Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the anti-LPS activity of the synthetic peptide AWRK6, which is derived from antimicrobial peptide dybowskin-2CDYa, has been investigated in vitro and in vivo. The positively charged α-helical AWRK6 was found to be effective in blocking the binding of LBP (LPS binding protein) with LPS in vitro using ELISA. In a murine endotoxemia model, AWRK6 offered satisfactory protection efficiency against endotoxemia death, and the serum levels of LPS, IL-1β, IL-6, and TNF-α were found to be attenuated using ELISA. Further, histopathological analysis suggested that AWRK6 could improve the healing of liver and lung injury in endotoxemia mice. The results of real-time PCR and Western blotting showed that AWRK6 significantly reversed LPS-induced TLR4 overexpression and IκB depression, as well as the enhanced IκB phosphorylation. Additionally, AWRK6 did not produce any significant toxicity in vivo and in vitro. In summary, AWRK6 showed efficacious protection from LPS challenges in vivo and in vitro, by blocking LPS binding to LBP, without obvious toxicity, providing a promising strategy against LPS-induced inflammatory responses. MDPI 2018-02-17 /pmc/articles/PMC5855822/ /pubmed/29463000 http://dx.doi.org/10.3390/ijms19020600 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Qiuyu Jin, Lili Wang, Huan Tai, Sijia Liu, Hongsheng Zhang, Dianbao AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title | AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title_full | AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title_fullStr | AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title_full_unstemmed | AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title_short | AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response |
title_sort | awrk6, a synthetic cationic peptide derived from antimicrobial peptide dybowskin-2cdya, inhibits lipopolysaccharide-induced inflammatory response |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855822/ https://www.ncbi.nlm.nih.gov/pubmed/29463000 http://dx.doi.org/10.3390/ijms19020600 |
work_keys_str_mv | AT wangqiuyu awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse AT jinlili awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse AT wanghuan awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse AT taisijia awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse AT liuhongsheng awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse AT zhangdianbao awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse |